title: Respiratory epithelial adenomatoid hamartoma: a poorly recognized entity with mast cell recruitment and frequently associated with nasal polyposis.
abstract: Respiratory epithelial adenomatoid hamartoma (REAH) is regarded as a rare tumor of the nasal cavity. The mechanisms driving the development of REAH are unknown, and its nature as a benign tumor, hamartoma, or reactive inflammatory process is still open to discussion. A total of 150 consecutive patients operated on for nasal polyposis (NP) were extensively checked for the diagnosis of REAH. The profile of REAH occurring in association with NP was compared with solitary REAH in a series of 19 cases. The possible role of tryptase-producing mast cells (MC) and of metalloproteinases MMP2 and MMP9 in REAH development was investigated by immunohistochemistry. REAH lesions were identified in 35% of patients who had surgery for NP (53/150). The distribution of the lesions suggested that REAH originated in the olfactory cleft. Solitary REAH occurred about 20 times less frequently than those observed in an NP context but shared the same microscopic characteristics. Tryptase-producing MCs were recruited at high density in REAH (135/10 hpf), compared with inflammatory polyps (45/10 hpf; P<0.00005) and hypertrophied turbinates (51/10 hpf; P<0.0005). REAH also showed constant MMP9 expression and to a lesser degree MMP2 expression in epithelial cells. If solitary REAH is a relatively rare lesion, we demonstrated that an exhaustive sampling allows the detection of a high proportion of NP-associated REAH, sharing the same clinical and histologic characteristics with solitary REAH. Tryptase-producing MCs, possibly in association with MMP expression, may play a central role in REAH formation.
authors.affiliation: Departments of *Pathology §Radiology ∥Centre de Ressources Biologiques ‡Department of Otolaryngology - Head and Neck Surgery, CHU †INSERM U954, Medical Faculty of Nancy, Université de Lorraine, Nancy, France.
authors.forename: Guillaume
authors.initials: G
authors.lastname: Gauchotte
authors.forename: Beatrice
authors.initials: B
authors.lastname: Marie
authors.forename: Patrice
authors.initials: P
authors.lastname: Gallet
authors.forename: Duc Trung
authors.initials: DT
authors.lastname: Nguyen
authors.forename: Marion
authors.initials: M
authors.lastname: Grandhaye
authors.forename: Roger
authors.initials: R
authors.lastname: Jankowski
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Vignaud
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000032:analysis; D001706:Biopsy; D004724:Endoscopy; D005260:Female; D006222:Hamartoma / Q000201:enzymology / Q000473:pathology* / Q000601:surgery; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008407:Mast Cells / Q000201:enzymology / Q000473:pathology*; D020778:Matrix Metalloproteinase 2 / Q000032:analysis; D020780:Matrix Metalloproteinase 9 / Q000032:analysis; D008875:Middle Aged; D009297:Nasal Mucosa / Q000201:enzymology / Q000473:pathology* / Q000601:surgery; D009298:Nasal Polyps / Q000201:enzymology / Q000473:pathology* / Q000601:surgery; D009668:Nose Diseases / Q000201:enzymology / Q000473:pathology* / Q000601:surgery; D009669:Nose Neoplasms / Q000201:enzymology / Q000473:pathology* / Q000601:surgery; D011237:Predictive Value of Tests; D014057:Tomography, X-Ray Computed; D053802:Tryptases / Q000032:analysis; D055815:Young Adult
chemical_list: D014408:Biomarkers, Tumor; D053802:Tryptases; C522361:MMP2 protein, human; D020778:Matrix Metalloproteinase 2; C579270:MMP9 protein, human; D020780:Matrix Metalloproteinase 9